GVK BIO in Trouble

GVK BIO in Trouble
Case Code: BSTR488
Case Length: 10 Pages
Period: 2014-2015
Pub Date: 2016
Teaching Note: Not Available
Price: Rs.500
Organization: GVK BIO
Industry: Pharmaceutical Industry
Countries: India
Themes: Business, Operational Strategy, Management
GVK BIO in Trouble
Abstract Case Intro 1 Case Intro 2 Excerpts


This case is about the problems faced by India-based pharmaceutical research company GVK BIO due to the ban imposed by the European Union (EU) suspending sales and distribution of around 700 generic drugs being sold by various global pharma companies for which clinical trials were conducted at the GVK BIO facility in Hyderabad. The case focuses on the alleged manipulation of clinical trials at GVK Bio. It concludes by discussing the impact of the ban on the reputation of GVK BIO and how winning back the trust of global regulators would be a tough task for GVK BIO going forward.


The case is structured to achieve the following teaching objectives:

  • Understand the importance of clinical trials in the drug discovery process
  • Understand the implications of the EU ban on GVK BIO’s business
  • Explore ways in which GVK BIO can salvage its reputation and the measures it has to take to improve transparency in clinical trials



GVK BIO, Clinical trials, Drug discovery, Pharmaceutical industry, Generic drugs, Contract Research Organization, European Union ban, European Medicines Agency (EMA)

Buy this case study (Please select any one of the payment options)

Price: Rs.500
Price: Rs.500
PayPal (11 USD)

Custom Search